Researchers unlock new insights into hard-to-treat neuroendocrine tumors

Researchers at Boston Medical Center and Dana-Farber Cancer Institute conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single cell resolution, unlocking new insights into this rare and often hard-to-treat cancer.

AbbVie licenses OSE’s chronic inflammation therapy for $48m upfront

Share this article OSE-230 is a ChemR23, a G-Protein coupled receptor (GPCR) targeting monoclonal antibody. Image Credit: Poetra.RH / Shutterstock. AbbVie has signed a partnership

February 28, 2024

Peanut Allergy Toothpaste Shows Promise in Phase I Trial

ANAHEIM, Calif. — A specially formulated toothpaste that’s designed to alleviate peanut allergy via oral mucosal exposure appears to be safe, according to findings from

November 14, 2023

Private Medicare plans collect billions for care veterans are actually getting from VA

One ad shows two older men talking jovially on a front porch, “Vietnam veteran” visible on one of their hats. Another shows an older man

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.